Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 19, Issue 3, 2004, Pages 657-663

  de Barros Gueiros, José Edevanilson ^a   Chammas, Maria Cristina ^a   Gerhard, Renê ^a   da Silva Dias Boilesen, Camila Freire Dente ^a   de Oliveira, Ilka Regina Souza ^a   Moysés, Rosa Maria Affonso ^a   Jorgetti, Vanda ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Calcitriol injection; Ethanol injection; Ki 67; Parathyroid cellular proliferation; Secondary hyperparathyroidism; Sonographic guidance

Indexed keywords

ALCOHOL; CALCITRIOL; CALCIUM ION; KI 67 ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; ASPIRATION BIOPSY; BURNING SENSATION; CALCIUM BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DYSPHONIA; FEMALE; HEMATOMA; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INJECTION PAIN; KIDNEY FAILURE; MALE; NODULAR HYPERPLASIA; ORGAN SIZE; PARATHYROID CELL; PARATHYROIDECTOMY; PERCUTANEOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; TREATMENT FAILURE;

ADULT; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CELL DIVISION; ETHANOL; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INJECTIONS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PARATHYROID GLANDS; SEVERITY OF ILLNESS INDEX; SOLVENTS; TREATMENT FAILURE;

EID: 1342263701     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg586     Document Type: Article

References (23)

1. Amann K, Gross ML, London GM, Ritz E. Hyperphosphataemia - a silent killer of patients with renal failure? Nephrol Dial Transplant 1999; 14: 2085-2087
2. Malberti F, Marcelli D, Ferruccio C, Limido A, Spotti D, Locatelli F. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 2001; 12: 1242-1248
3. Tominaga Y. Mechanism of parathyroid tumourigenesis in uraemia. Kidney Int 1999; 14 [Suppl 14]: 63-65
4. Solbiati L, Giangrande A, De Pra L, Cantú P, Ravetto C. Percutaneous ethanol injection of parathyroid tumors under us guidance: treatment for secondary hyperparathyroidism. Radiology 1985; 155: 607-610
5. Kitaoka M, Fukagawa M, Fukuda N, Yi H, Ogata E, Kurokawa K. Direct injection of calcitriol into enlarged parathyroid glands in chronic dialysis patients with severe parathyroid hyperfunction. Nephrology 1995; 1: 563-567
6. Fukagawa M, Kitaoka M, Yi H et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994; 68: 221-228
7. Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H. Histology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997; 13: 78-86
8. Fletcher S, Kanagasundaram NS, Rayner HC et al. Assesment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 1998; 13: 1311-1317
9. Giangrande A, Catiglioni A, Solbiati, L, Allaria P. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992; 7: 412-421
10. Kakuta T, Fukagawa M, Fujisaki T et al. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 1999; 33: 109-119
11. Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kurokawa K. Selective percutaneous injection therapy (PEIT) of the parathyroid in chronic dialysis patients - the Japanese strategy. Nephrol Dial Transplant 1999; 14: 2574-2577
12. Kitaoka M, Fukagawa M, Ogata E, Kurokawa K. Reduction of cell mass by ethanol injection in chronic dialysis patients. Kidney Int 1994; 46: 1110-1117
13. Rodriguez M, Canalejo A, Garfia B, Aguilera E, Almaden Y. Pathogenesis of refractory hyperparathyroidism. Kidney Int 2002; 61 [Suppl 80]: 155-160
14. Fukuda N, Tanaka H, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density in associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
15. Shiizaki K, Hatamura H, Negi S et al. Clinical effects and changes of parathyroid cells induced by percutaneous Maxacalcitol infection therapy in patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002; 13: 194A
16. Ferreira MA. Diagnosis of renal osteodystrophy: when and how to use the biochemical markers and non-invasive methods: when bone biopsy is need. Nephrol Dial Transplant 2000; 15 [Suppl 15]: 8-14
17. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75: 145-150
18. Chudek J, Kokot F, Witkowick J et al. No marked apoptosis of parathyroid cells after intraparathyroid injections of Calcijex - observations in a patient with tertiary hyperparathyroidism after successful renal transplantation. Nephrol Dial Transplant 2000; 15: 424-425
19. Abbati A, Skarulis M, Shawker T, Solomon D. Ultrasound-guided fine-needle aspiration of parathyroid lesions: a morphological and immunocytochemical approach. Hum Pathol 1995; 26: 338-343
20. Halbauer M, Crepinko I, Brzac TH, Simonovic I. Fine needle aspiration cytology in the preoperative diagnosis of ultrasonically enlarged parathyroid glands. Acta Cytolog 1991; 35: 728-735
21. Parfitt AM. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 1997; 52: 3-9
22. Abonna GC, Apotti M, Asparri G, Bussolati G. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 1995; 26: 135-138
23. Wang Q, Palnitkar S, Parfitt AM. The basal rate of cell proliferation in normal human parathyroid tissue: implications of pathogenesis of hyperparathyroidism. Clin Endocrinol 1997; 46: 343-349